Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
134.92
+1.75 (1.31%)
Feb 21, 2025, 4:00 PM EST - Market closed
Abbott Laboratories Analyst Ratings
Total Analysts
17
Consensus Rating
Buy
Price Target
$131.41
Upside
-2.60%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $149 → $158 | Buy | Maintains | $149 → $158 | +17.11% | Jan 27, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $135 | Buy | Reiterates | $135 | +0.06% | Jan 23, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $133 → $136 | Buy | Maintains | $133 → $136 | +0.80% | Jan 23, 2025 |
| Stifel | Stifel | Strong Buy Maintains $130 → $135 | Strong Buy | Maintains | $130 → $135 | +0.06% | Jan 23, 2025 |
| UBS | UBS | Strong Buy Maintains $146 → $148 | Strong Buy | Maintains | $146 → $148 | +9.69% | Jan 23, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $135 | Buy | Reiterates | $135 | +0.06% | Jan 21, 2025 |
| Barclays | Barclays | Buy Maintains $143 → $149 | Buy | Maintains | $143 → $149 | +10.44% | Nov 5, 2024 |
| Bernstein | Bernstein | Buy Maintains $133 → $138 | Buy | Maintains | $133 → $138 | +2.28% | Oct 17, 2024 |
| UBS | UBS | Strong Buy Maintains $143 → $146 | Strong Buy | Maintains | $143 → $146 | +8.21% | Oct 17, 2024 |
| Jefferies | Jefferies | Hold Maintains $120 → $125 | Hold | Maintains | $120 → $125 | -7.35% | Oct 17, 2024 |
| Mizuho | Mizuho | Hold Maintains $115 → $130 | Hold | Maintains | $115 → $130 | -3.65% | Oct 17, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $131 → $133 | Buy | Maintains | $131 → $133 | -1.42% | Oct 17, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $107 → $117 | Hold | Maintains | $107 → $117 | -13.28% | Oct 17, 2024 |
| Raymond James | Raymond James | Buy Maintains $122 → $129 | Buy | Maintains | $122 → $129 | -4.39% | Oct 14, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $125 → $130 | Buy | Maintains | $125 → $130 | -3.65% | Oct 8, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $130 | Buy | Initiates | $130 | -3.65% | Oct 8, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.